Laboratory Corporation of America Holdings (LH)

Name: Laboratory Corporation of America Holdings (LH) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Health Care · Wall Street (EE. UU.) · Última actualización: 2026-11-04

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.

Cifras clave

Capitalización bursátil: $29 billion
Ingresos (ejercicio cerrado en 2025-12-31): $14.0B
Beneficio neto: $876M
Margen bruto: 26.8%
Margen neto: 6.3%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	TTM → 2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Ingresos totales	$14.6B	$14.0B	$13.0B	$12.2B	$11.9B	$13.1B	$14.0B	$11.6B	$11.3B	$10.4B	$9.6B	$8.7B	$6.0B	$5.8B	$5.7B	$5.5B	$5.0B	$4.7B	$4.5B	$4.1B	$3.6B
Beneficio bruto	$4.1B	$3.7B	$3.6B	$3.4B	$3.7B	$5.0B	$5.0B	$3.3B	$3.2B	$3.5B	$3.2B	$2.9B	$2.2B	$2.2B	$2.2B	$2.3B	$2.1B	$2.0B	$1.9B	$1.7B	$1.5B
% de margen bruto	28.0%	26.8%	27.9%	27.7%	31.3%	38.0%	35.4%	28.1%	28.0%	33.2%	33.0%	33.5%	36.6%	38.3%	39.7%	41.0%	41.9%	42.0%	41.6%	41.6%	42.6%
Ingresos operativos (EBIT)	$1.6B	$1.5B	$1.1B	$726M	$1.4B	$3.0B	$2.4B	$1.3B	$1.3B	$1.4B	$1.3B	$1.0B	$910M	$991M	$1.0B	$948M	$979M	$936M	$843M	$777M	$697M
% de margen operativo	11.1%	10.9%	8.3%	6.0%	12.1%	23.2%	17.5%	11.5%	11.7%	13.1%	13.6%	11.6%	15.1%	17.1%	18.1%	17.1%	19.6%	19.9%	18.7%	19.1%	19.4%
Ingresos netos	$1.0B	$876M	$746M	$418M	$1.3B	$2.4B	$1.6B	$824M	$884M	$1.3B	$732M	$437M	$511M	$574M	$583M	$520M	$558M	$543M	$464M	$477M	$432M
% de margen neto	6.9%	6.3%	5.7%	3.4%	10.8%	18.1%	11.1%	7.1%	7.8%	12.2%	7.6%	5.0%	8.5%	9.9%	10.3%	9.4%	11.2%	11.6%	10.3%	11.7%	12.0%
EBITDA	—	$2.0B	$1.8B	$1.3B	$2.0B	$3.7B	$3.3B	$2.1B	$2.1B	$1.8B	$1.8B	$1.6B	$1.2B	$1.2B	$1.3B	$1.2B	$1.2B	$1.1B	$1.0B	$990M	$853M
Beneficio por acción (EPS)	$12.19	$10.46	$8.84	$4.77	$13.96	$24.38	$15.88	$8.35	$8.61	$12.21	$7.02	$4.34	$5.92	$6.25	$5.99	$5.11	$5.30	$4.98	$4.10	$3.93	$3.24
Acciones en circulación (M)	—	84M	84M	88M	92M	98M	98M	99M	103M	104M	104M	101M	86M	92M	97M	102M	105M	109M	113M	121M	133M

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de LH. /companies/us/LH

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.